Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2024-04-29 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
监事会2023年度工作报告
Management Reports Classification · 95% confidence The document is titled as the "2023年度监事会工作报告" which translates to the "2023 Supervisory Board Work Report" of the company. It details the supervisory board's activities, meetings, oversight of company operations, financial status, internal controls, related party transactions, and outlook for 2024. The content is a comprehensive report on the supervisory board's work and oversight for the year 2023, including financial and operational supervision but does not contain full financial statements or detailed financial results typical of an Annual Report (10-K) or Interim Report (IR). It is not an announcement or a brief summary but a detailed report from the supervisory board. This fits best under the category of Management Reports (MDA), which includes management's detailed explanation of financial results, business trends, and outlook, especially from a supervisory or oversight perspective. The document length (4881 characters) is sufficient for a substantive report rather than a brief announcement. Therefore, the classification is MDA with high confidence.
2024-04-29 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report' for the fiscal year 2023. It contains an auditor's opinion on the effectiveness of the company's internal control over financial reporting as of December 31, 2023. The document is issued by a registered accounting firm and includes details about the responsibilities of the company and auditors, inherent limitations of internal control, and the audit opinion. It is a standalone audit report focused on internal control effectiveness, not a full annual report or other types of filings. The document length is short (688 characters), but it contains substantive audit content, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2023
2024-04-29 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2023 Annual Report Summary" of 绿康生化股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2023, including total assets, net profit, earnings per share, and quarterly financial data. It also includes company business descriptions, shareholder information, and important corporate events during the year. The length of the document (7588 characters) and the presence of substantive financial data and analysis confirm it is a financial report rather than a mere announcement. The document is not a transcript, proxy statement, or a regulatory filing. It is a comprehensive yearly report covering company activity and financial performance, fitting the definition of an Annual Report (10-K). FY 2023
2024-04-29 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of the company 绿康生化股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be voted on, including board elections, financial reports, profit distribution plans, and amendments to the company charter. It also contains instructions for shareholders on registration and proxy voting. The document does not contain actual financial statements or detailed financial analysis but rather serves as a formal notification and procedural guide for the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2024-04-29 Chinese
上市公司独立董事候选人声明与承诺（吕虹）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a listed company. It includes multiple attestations about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is focused on governance and compliance related to board membership qualifications. This type of document fits best under Board/Management Information (MANG), as it relates to announcements or statements about board members or candidates for board positions.
2024-04-29 Chinese
-关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by the company 绿康生化股份有限公司. It references the adoption of a new accounting standard issued by the Ministry of Finance and states that the change does not require shareholder approval and will not materially affect financial results. The document includes opinions from the board of directors and the supervisory board, and it is titled as an announcement (公告) rather than a full financial report. The document length is short (1368 characters), and it does not contain actual financial statements or detailed financial data. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Audit Report (AR). It is a regulatory announcement about accounting policy changes, which fits best under Regulatory Filings (RNS).
2024-04-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.